Centre Testing International Group (300012) Q3 2025 earnings summary

Executive summary

• Revenue for Q3 2025 reached ¥1.74 billion, up 8.53% year-over-year, with net profit attributable to shareholders at ¥344.96 million, up 11.24% year-over-year.

• Year-to-date revenue was ¥4.70 billion, up 6.95% year-over-year, and net profit attributable to shareholders was ¥812.24 million, up 8.78% year-over-year.

• Operating cash flow for Q3 surged 67.60% year-over-year to ¥421.35 million; year-to-date operating cash flow increased 117.88% to ¥596.15 million.

Financial highlights

• EBITDA for Q3 was ¥525.29 million, up 14.48% year-over-year; year-to-date EBITDA was ¥1.32 billion, up 8.18%.

• Basic and diluted EPS for Q3 were both ¥0.2062, up 10.98% year-over-year; year-to-date EPS was ¥0.4855, up 8.76%.

• Total assets at period end were ¥9.86 billion, up 4.29% from the previous year-end; shareholders’ equity was ¥7.56 billion, up 9.33%.

• Non-recurring gains for Q3 totaled ¥18.28 million, mainly from government subsidies and investment income.

Outlook and guidance

• No explicit forward-looking guidance provided, but strong cash flow and profit growth indicate positive momentum.